CSP exam test 2024 (specialty pharmacy)With Correct
Answers!!
PDC calculation - ✔✔(# of unique days with supply / number of days in a period) x 100
Jak inhibitor - ✔✔Xeljanz (tofacitinib)
Cholesterol-elevating medication - ✔✔Actemra (toclizumab)
Shingles vaccine safe with TNF inhibitors - ✔✔Shingrix
Neutropenia risk - ✔✔Taltz (ixekizumab)
Psoriasis medication without tuberculosis screening - ✔✔Otezla (apremilast)
Standard starting dose for Taltz (ixekizumab) in psoriatic arthritis - ✔✔160mg subcutaneously once,
followed by 80mg subcutaneously every 4 weeks
Medication recommendation for severe dermatitis in a 45 y/o patient - ✔✔Dupixent (dupilumab)
Starting dose for Stelara (ustekinumab) in psoriasis - ✔✔Inject 45 mg subcutaneously at weeks 0 and
4, followed by 45 mg every 12 weeks
Oral oncology medication without caution in hepatic impairment - ✔✔Ibrance (palbociclib)
Non-side effect of Zytiga (abiraterone acetate) - ✔✔Mucositis
Smoking effect on Tarceva (erlotinib) levels - ✔✔Smoking decreases Tarceva levels and the
medication will be less effective if he continues to smoke
Oral oncology agents taken with food - ✔✔Xeloda (capecitabine) and Temodar (temozolomide)
Recommended oncology treatment for metastatic HER 2+ breast cancer - ✔✔Tykerb (lapatinib) in
combination with Xeloda (capecitabine)
Incorrect oral chemotherapy cycle - ✔✔Afinitor (everolimus) 10mg daily for 21 days, then 7 days off
Grapefruit and grapefruit juice interaction with oral chemotherapy - ✔✔Zytiga (abiraterone acetate)
Transition from Exjade (deferasirox) to Jadenu (deferasirox) - ✔✔The Jadenu dose should be started
at a dosage 30% less than current Exjade dose
Oral antiandrogen for metastatic castration-resistant prostate cancer - ✔✔Xtandi (enzalutamide)
160mg once daily
Answers!!
PDC calculation - ✔✔(# of unique days with supply / number of days in a period) x 100
Jak inhibitor - ✔✔Xeljanz (tofacitinib)
Cholesterol-elevating medication - ✔✔Actemra (toclizumab)
Shingles vaccine safe with TNF inhibitors - ✔✔Shingrix
Neutropenia risk - ✔✔Taltz (ixekizumab)
Psoriasis medication without tuberculosis screening - ✔✔Otezla (apremilast)
Standard starting dose for Taltz (ixekizumab) in psoriatic arthritis - ✔✔160mg subcutaneously once,
followed by 80mg subcutaneously every 4 weeks
Medication recommendation for severe dermatitis in a 45 y/o patient - ✔✔Dupixent (dupilumab)
Starting dose for Stelara (ustekinumab) in psoriasis - ✔✔Inject 45 mg subcutaneously at weeks 0 and
4, followed by 45 mg every 12 weeks
Oral oncology medication without caution in hepatic impairment - ✔✔Ibrance (palbociclib)
Non-side effect of Zytiga (abiraterone acetate) - ✔✔Mucositis
Smoking effect on Tarceva (erlotinib) levels - ✔✔Smoking decreases Tarceva levels and the
medication will be less effective if he continues to smoke
Oral oncology agents taken with food - ✔✔Xeloda (capecitabine) and Temodar (temozolomide)
Recommended oncology treatment for metastatic HER 2+ breast cancer - ✔✔Tykerb (lapatinib) in
combination with Xeloda (capecitabine)
Incorrect oral chemotherapy cycle - ✔✔Afinitor (everolimus) 10mg daily for 21 days, then 7 days off
Grapefruit and grapefruit juice interaction with oral chemotherapy - ✔✔Zytiga (abiraterone acetate)
Transition from Exjade (deferasirox) to Jadenu (deferasirox) - ✔✔The Jadenu dose should be started
at a dosage 30% less than current Exjade dose
Oral antiandrogen for metastatic castration-resistant prostate cancer - ✔✔Xtandi (enzalutamide)
160mg once daily
